SCHEMBL2767436

SCHEMBL2767436

Oc1ccc(N2CCN(CCc3ccccc3)CC2)c(Cl)c1

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.57
HSP90AB1 P08238 1/20 0.57
SIGMAR1 Q99720 2/20 0.56
HTR1A P08908 2/20 0.55
DRD2 P14416 1/20 0.55
OPRM1 P35372 1/20 0.53
MEN1 O00255 1/20 0.52
ALDH1A1 P00352 1/20 0.52
KMT2A Q03164 1/20 0.52
ADRA1D P25100 1/20 0.52
ADRA1A P35348 1/20 0.52
ADRA1B P35368 1/20 0.52
SLC6A2 P23975 2/20 0.52
SLC6A4 P31645 2/20 0.52
HTR7 P34969 1/20 0.52
CASP1 P29466 1/20 0.50
CASP4 P49662 1/20 0.50
CASP5 P51878 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2766780 0.85 ADRA1D (0.54) SIGMAR1HTR1ADRD2OPRM1MEN1
SCHEMBL2765952 0.85 MEN1 (0.61) HTR1ADRD2OPRM1MEN1ALDH1A1
SCHEMBL2767088 0.83 HTR1A (0.51) SIGMAR1HTR1ADRD2OPRM1MEN1
SCHEMBL2767759 0.82 HRH3 (0.60) SIGMAR1HTR1ADRD2ADRA1DADRA1A
SCHEMBL2766366 0.78 HTR1A (0.78) SIGMAR1HTR1ADRD2OPRM1ALDH1A1
SCHEMBL2765513 0.77 SIGMAR1 (0.65) HSP90AA1HSP90AB1SIGMAR1HTR1ADRD2
SCHEMBL11476179 0.75 DRD2 (0.57) SIGMAR1DRD2
SCHEMBL11497577 0.75 HTR1A (0.78) SIGMAR1HTR1ADRD2OPRM1ADRA1D
SCHEMBL6056974 0.74 SLC6A3 (0.83) SIGMAR1HTR1ADRD2MEN1KMT2A
SCHEMBL14407778 0.74 SLC6A3 (0.83) SIGMAR1HTR1ADRD2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1627871-B1 CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE ASKA PHARM CO LTD (JP) 2010-04-14 EP disclosed
US-7449466-B2 Cyclic aminophenyl sulfamate derivative ASKA PHARMACEUTICAL CO., LTD. (JP) 2008-11-11 US disclosed
US-20060189625-A1 Cyclic aminophenyl sulfamate derivative ASKA PHARMACEUTICAL CO., LTD. (JP) 2006-08-24 US disclosed
EP-1627871-A1 CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE Teikoku Hormone Mfg. Co., Ltd. (JP) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189625-A1 Cyclic aminophenyl sulfamate derivative SHBG, STS, ARSA HSP90AA1 2717/4885HSP90AB1 1604/4885SIGMAR1 1062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.